Koller, Dora http://orcid.org/0000-0002-0415-0466
Friligkou, Eleni http://orcid.org/0009-0003-3682-0991
Stiltner, Brendan
Pathak, Gita A.
Løkhammer, Solveig
Levey, Daniel F. http://orcid.org/0000-0001-8431-9569
Zhou, Hang http://orcid.org/0000-0002-7694-6391
Hatoum, Alexander S. http://orcid.org/0000-0002-8002-7267
Deak, Joseph D. http://orcid.org/0000-0002-0540-6080
Kember, Rachel L. http://orcid.org/0000-0001-8820-2659
Treur, Jorien L.
Kranzler, Henry R. http://orcid.org/0000-0002-1018-0450
Johnson, Emma C. http://orcid.org/0000-0003-0394-777X
Stein, Murray B. http://orcid.org/0000-0001-9564-2871
Gelernter, Joel http://orcid.org/0000-0002-4067-1859
Polimanti, Renato http://orcid.org/0000-0003-0745-6046
Article History
Received: 10 July 2023
Revised: 18 January 2024
Accepted: 22 January 2024
First Online: 15 February 2024
Competing interests
: RP reports a research grant from Alkermes. RP and JG are paid for their editorial work in the journal Complex Psychiatry. JG and HRK hold US patent 10,900,082 titled: “Genotype-guided dosing of opioid agonists,” issued January 26, 2021. HRK is a member of advisory boards for Dicerna Pharmaceuticals, Sophrosyne Pharmaceuticals, and Enthion Pharmaceuticals; a consultant to Sobrera Pharmaceuticals; the recipient of research funding and medication supplies for an investigator-initiated study from Alkermes; and a member of the American Society of Clinical Psychopharmacology’s Alcohol Clinical Trials Initiative, which was supported in the past 3 years by Alkermes, Dicerna, Ethypharm, Lundbeck, Mitsubishi, Otsuka, and Pear Therapeutics. MBS has in the past 3 years received consulting income from Actelion, Acadia Pharmaceuticals, Aptinyx, atai Life Sciences, Boehringer Ingelheim, Bionomics, BioXcel Therapeutics, Clexio, Delix Pharmaceuticals, EmpowerPharm, Engrail Therapeutics, GW Pharmaceuticals, Janssen, Jazz Pharmaceuticals, and Roche/Genentech; has stock options in Oxeia Biopharmaceuticals and EpiVario; and has been paid for editorial work on Depression and Anxiety (Editor-in-Chief), Biological Psychiatry (Deputy Editor), and UpToDate (Co-Editor-in-Chief for Psychiatry). The other authors declare no competing interests.